Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

SELL
$0.4 - $0.63 $3,986 - $6,278
-9,966 Reduced 61.66%
6,197 $2,000
Q2 2023

Aug 14, 2023

SELL
$0.51 - $0.67 $29,300 - $38,492
-57,452 Reduced 78.04%
16,163 $8,000
Q1 2023

May 15, 2023

BUY
$0.6 - $0.91 $24,858 - $37,702
41,431 Added 128.73%
73,615 $48,000
Q4 2022

Feb 13, 2023

SELL
$0.48 - $5.33 $7,412 - $82,305
-15,442 Reduced 32.42%
32,184 $20,000
Q3 2022

Nov 14, 2022

BUY
$4.65 - $7.37 $68,471 - $108,523
14,725 Added 44.76%
47,626 $231,000
Q2 2022

Aug 11, 2022

BUY
$4.21 - $11.15 $11,181 - $29,614
2,656 Added 8.78%
32,901 $152,000
Q1 2022

May 13, 2022

SELL
$8.48 - $18.1 $29,510 - $62,988
-3,480 Reduced 10.32%
30,245 $325,000
Q4 2021

Feb 11, 2022

BUY
$15.37 - $22.5 $360,657 - $527,962
23,465 Added 228.7%
33,725 $577,000
Q3 2021

Nov 04, 2021

SELL
$15.05 - $23.28 $1,339 - $2,071
-89 Reduced 0.86%
10,260 $183,000
Q2 2021

Aug 11, 2021

BUY
$15.31 - $24.63 $158,443 - $254,895
10,349 New
10,349 $200,000

Others Institutions Holding TIL

About Instil Bio, Inc.


  • Ticker TIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,694,000
  • Market Cap $2.67B
  • Description
  • Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...
More about TIL
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.